Modelling vortex interactions reveals distinct patterns of brain reconfiguration following psilocybin and escitalopram
Year: 2026
Type: preprint
Abstract: Major depressive disorder is a leading cause of disability, yet how interventions reorganise brain dynamics remains poorly understood. Here, we investigated how psilocybin and escitalopram reshape brain dynamics in depression using pre- and post-treatment resting-state functional magnetic resonance imaging (fMRI) from a double-blind randomised controlled trial ( NCT03429075 ). We compared two whole-brain modelling approaches: conventional signal-space modelling describing interactions between regional brain signals, and vortex-space modelling capturing interactions between evolving patterns of local synchronisation. This represents the first application of vortex-space modelling to a psychiatric disorder. Vortex space was more sensitive than signal space in most analyses, including distinguishing treatment-related brain states, relating baseline connectivity to clinical improvement and predicting response to escitalopram. Our results further revealed distinct patterns of reorganisation following the two interventions. Psilocybin produced widespread increases in vortex-space effective connectivity and reduced network modularity, whereas escitalopram showed no comparable changes. Despite these differences, greater increases in brain turbulence (i.e., spatiotemporal variability in local synchronisation) were associated with greater symptom reduction in both treatments, with a significant post-treatment increase in responders. These findings suggest that psilocybin and escitalopram may reorganise brain dynamics in markedly different ways and yet share dynamical features associated with clinical improvement. Overall, vortex-space modelling offers a promising framework for characterising brain dynamics in depression and its successful treatment.
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: green
Funders: Israel Cancer Research Fund, Alexander Mosley Charitable Trust, National Institute for Health and Care Research, Imperial College London, Danmarks Grundforskningsfond, Carlsbergfondet, Generalitat de Catalunya, HORIZON EUROPE Framework Programme, Agència de Gestió d'Ajuts Universitaris i de Recerca, European Regional Development Fund, Agencia Estatal de Investigación
OpenAlex ID: W7236617434
